CompletedPHASE1, PHASE2NCT02829268
A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
Studying Wolfram syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Fumihiko Urano, MD, MDWashington University School of Medicine
- Intervention
- dantrolene sodium(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 5-60 years · All sexes
- Timeline
- 2017 – 2023
Study locations (1)
- Washington University School of Medicine, St Louis, Missouri, United States
Collaborators
National Institutes of Health (NIH) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02829268 on ClinicalTrials.govOther trials for Wolfram syndrome
Additional recruiting or active studies for the same condition.